This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Peter Maccallum Cancer Institute. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Kristiina Huttunen: Innovator in Perforin Inhibition
Introduction
Kristiina Huttunen is a notable inventor based in Kuopio, Finland. She has made significant contributions to the field of pharmaceutical compounds, particularly in the area of perforin inhibition. Her work is essential for advancing therapeutic strategies in various medical conditions.
Latest Patents
Kristiina holds a patent for "Perforin inhibiting benzenesulfonamide compounds, preparation and uses thereof." This patent includes compounds of formula (1a) and pharmaceutically acceptable salts, solvates, and hydrates. The invention focuses on methods of modulating perforin activity on a cell, which is crucial for understanding immune responses and developing new treatments.
Career Highlights
Kristiina has established herself as a prominent figure in her field through her innovative research and patent contributions. Her work at the Peter MacCallum Cancer Institute has allowed her to collaborate with leading experts and contribute to groundbreaking research in cancer treatment.
Collaborations
Some of Kristiina's notable coworkers include Julie Ann Spicer and William Alexander Denny. Their collaborative efforts have further enhanced the impact of her research and innovations.
Conclusion
Kristiina Huttunen's contributions to perforin inhibition represent a significant advancement in pharmaceutical research. Her innovative work continues to pave the way for new therapeutic approaches in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile